Impacts of black box warning, national coverage determination, and risk evaluation and mitigation strategies on the inpatient on-label and off-label use of erythropoiesis-stimulating agents
May 1, 2013, 00:00
10.1016/j.jval.2013.03.614
https://www.valueinhealthjournal.com/article/S1098-3015(13)00685-2/fulltext
Title :
Impacts of black box warning, national coverage determination, and risk evaluation and mitigation strategies on the inpatient on-label and off-label use of erythropoiesis-stimulating agents
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00685-2&doi=10.1016/j.jval.2013.03.614
First page :
A127
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
158